These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 1667268

  • 1. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Socaciu C, Bara A, Silvestru C, Haiduc I.
    In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
    [Abstract] [Full Text] [Related]

  • 2. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Bara A, Socaciu C, Silvestru C, Haiduc I.
    Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
    [Abstract] [Full Text] [Related]

  • 3. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C, Socaciu C, Bara A, Haiduc I.
    Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
    Sathisha MP, Budagumpi S, Kulkarni NV, Kurdekar GS, Revankar VK, Pai KS.
    Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
    [Abstract] [Full Text] [Related]

  • 5. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P, Bag SP, Sur B, Khanam JA.
    Neoplasma; 1997 Jan; 44(3):197-201. PubMed ID: 9372863
    [Abstract] [Full Text] [Related]

  • 6. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
    Ivanitskii LP, Makukho LV.
    Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
    [No Abstract] [Full Text] [Related]

  • 7. Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
    Lialiaris TS, Papachristou F, Mourelatos C, Simopoulou M.
    Anticancer Drugs; 2009 Sep; 20(8):746-51. PubMed ID: 19584706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
    Mourelatos D, Dozi-Vassiliades J, Kotsis A, Gourtsas C.
    Cancer Res; 1988 Mar 01; 48(5):1129-31. PubMed ID: 3342394
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
    El-Sayed WA, Rashad AE, Awad SM, Ali MM.
    Nucleosides Nucleotides Nucleic Acids; 2009 Apr 01; 28(4):261-74. PubMed ID: 20183580
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
    Karki SS, Thota S, Darj SY, Balzarini J, De Clercq E.
    Bioorg Med Chem; 2007 Nov 01; 15(21):6632-41. PubMed ID: 17765549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H, Yoshiga K, Sakurai K, Tsumura M, Takada K.
    Anticancer Res; 1996 Nov 01; 16(1):381-7. PubMed ID: 8615640
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
    Yoshida N, Kiyohara T, Fukui M, Atsumi T, Ogino S, Inaba M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1980 Oct 01; 40(10):3810-4. PubMed ID: 7438064
    [Abstract] [Full Text] [Related]

  • 15. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
    Raghavendra NM, Gurubasavarajaswamy PM, Nagaranavile KS, Parameshwaran T.
    Arch Pharm Res; 2009 Mar 01; 32(3):431-6. PubMed ID: 19387588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The effects of CHIP (Pt IV) on the cytokinetics of Ehrlich ascites carcinoma cells].
    Cao J, Pan QC.
    Yao Xue Xue Bao; 1987 Feb 01; 22(2):93-7. PubMed ID: 3618242
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
    Elo HO, Lumme PO.
    Cancer Treat Rep; 1985 Sep 01; 69(9):1021-2. PubMed ID: 4028035
    [Abstract] [Full Text] [Related]

  • 20. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC, Ramos AL, Rehmann FJ, Sweeney NJ, Strohfeldt K, Tacke M, Queiroz ML.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):264-70. PubMed ID: 16513106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.